Skip To Main Content
Anne Barton on Muck Rack

Anne Barton

As seen in: Wiley Online Library, Science Magazine, New York Review of Books, Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anne

Contact Anne, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Development of a Complex Methotrexate Adherence Intervention Utilising

|
By Christopher J. Armitage, Anne Barton, Hannah Shafi
| Dove Medical Press
Introduction Rheumatoid arthritis (RA) is a chronic disease for which there is no known cure that affects ~1% of the adult population.1 The hallmark of RA is symmetrical joint inflammation which, when left untreated, can lead to joint destruction, disability, multimorbidity and reduced life expectancy by up to 10 years.2 RA treatment is predominantly aimed at controlling joint inflammation and early effective therapy reduces disability, joint damage and mortality.3,4 Conventional Synthetic...
Open in Who Shared Issue with article?

Machine Learning Analysis of Whole‐Blood Transcriptomics Data in Rheumatoid Arthritis Patients Treated with Adalimumab Identifies Predictive Biomarkers of Response

|
By Chuan Fu Yap, Nisha Nair, Ann Morgan, John D Isaacs, Ann Morgan, Anthony Wilson, Kimme Hyrich, Guillermo Barturen, Marta Gut, Ivo Gut, Anne Barton, Darren Plant Verified, María Riva‐Torrubia
| Wiley Online Library Verified
Supporting Information Filename Description art43255-sup-0001-Disclosureform.pdfPDF document, 3.6 MB Disclosure Form art43255-sup-0002-Supinfo.docxWord 2007 document , 1.1 MB Appendix S1: Supporting Information
Open in Who Shared View Duplicates (2) Issue with article?

Genetically Proxied Interleukin‐13 Inhibition Is Associated With Risk of Psoriatic Disease: A Mendelian Randomization Study

|
By Sizheng Zhao, Kimme Hyrich, Zenas Yiu, Anne Barton
| Wiley Online Library Verified
INTRODUCTION Inhibitors of the interleukin 13 (IL-13) pathway, such as dupilumab (dual interleukin 4 [IL-4]/IL-13 inhibitor), tralokinumab, and lebrikizumab (pure IL-13 inhibitors), were developed to treat atopic diseases including atopic dermatitis, chronic rhinosinusitis, and asthma.1-4 Musculoskeletal adverse events resembling seronegative spondyloarthritis have been reported after dupilumab initiation, but evidence is limited to case series and spontaneous pharmacovigilance with uncertain...
Open in Who Shared View Duplicates (3) Issue with article?
See all 7 licensed articles (8 Total)